Government Manufacturing Pharmaceutical 
Mad in America
SEPTEMBER 7, 2024
Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.
Tanveer Naseer
MAY 16, 2011
Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Obviously, it’s pretty easy to assail government bureaucracy, but how about industry?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
OCTOBER 10, 2023
With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.
Mad in America
OCTOBER 18, 2023
For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.
Mad in America
SEPTEMBER 14, 2024
As Rob Wipond writes in Your Consent is Not Required: The Rise in Psychiatric Detentions, Forced Treatment, and Abusive Guardianships : “Today, good statistics are hard to come by—federal, state, and provincial governments don’t gather them, don’t gather them in full, or don’t share them publicly.
Workplace Insight
DECEMBER 14, 2023
It is striking how weighted Ireland’s export figures are to the life sciences, medical and pharmaceutical industries craved by the UK Just how significant is apparent when comparing the UK with Ireland. We are at something of a tipping point if we don’t make the right decisions now,” said Emma Walmsley.
Inside Workplace Wellness
AUGUST 1, 2018
The arrangement would have been the first agreement with a manufacturer for outcomes-based pricing. The demise of the CMS deal illustrates how difficult it is to figure out how much government health programs should pay for expensive treatments whose long-term benefits are still unclear. 3 Evaluate your contract terms.
Expert insights. Personalized for you.
144 
Let's personalize your content